SHREVEPORT, La. - The Center for Molecular Imaging and Therapy, a subsidiary of BRF, proudly announces its new collaboration with the Brain Health Alliance as an imaging site in the nationwide EPSMS ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Advances in the ability to measure chronic, active inflammation in MS using MRI and positron ...

A new study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, suggests positron emission tomography (PET) brain scans could reveal hidden inflammation ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Matthew Brier, MD, ...

Current conventional imaging will continue to impact our daily care of MS patients for years to come. Better guidelines related to undesirable disease activity seen on MRI will need to be developed ...

Researchers from Florey Neuroscience Institutes, Monash University and Olivia Newton-John Cancer Research Institute have identified fluorine-radiolabeled compounds acting as tyrosine-protein kinase ...

Women with Relapsing-Remitting Multiple Sclerosis (RRMS) needed for brain-imaging study The Neuroinflammation, Pain, and Fatigue Lab is looking for women with relapsing-remitting Multiple Sclerosis ...

Research at Bristol Myers Squibb Co. has led to the development of [11]-carbon-labeled compounds targeting Bruton tyrosine kinase (BTK) as positron emission tomography (PET) imaging agents for the ...

Dr. J. William Lindsey, Director of Multiple Sclerosis and Neuroimmunology at McGovern Medical School, UTHealth Houston, discusses how these social determinants of health impact the disease. (2:35) Is ...